Corcept Therapeutics | CORT - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Acadia Pharmaceuticals USD 28.32M 3.52M 2026-06
Alaunos Therapeutics USD 0 18K 2024-09
ANI Pharmaceuticals USD 119.8M 5.3M 2026-06
Ardelyx USD 4.81M 6.04M 2026-03
Aurora Cannabis CAD 8.22M 80.38M 2026-03
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Canopy Growth CAD 62.98M 9.91M 2026-03
Corcept Therapeutics USD 4.06M 1.18M 2026-06
Eli Lilly USD 3.27B 309M 2026-06
J&J USD 8B 67M 2026-06
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Merck USD 3.14B 200M 2026-06
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novartis USD 3.71B 251M 2026-06
Novartis USD 3.46B 83M 2026-03
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 58.49M 7.75M 2026-06
Pfizer USD 4.09B 498M 2026-06
Supernus Pharmaceuticals USD 59M 9.97M 2026-06
TG Therapeutics USD 41.19M 7.68M 2026-06